Aesthetic Device Cost & ROI Guide

RF microneedling (Morpheus8, Vivace, Secret RF) typically ranges $80,000–$150,000 new; used units $40,000–$70,000. Fractional laser (CO₂, erbium) runs $60,000–$200,000 depending on footprint and power. IPL/broadband light systems cost $40,000–$100,000. Radiofrequency skin tightening (Thermage, Exilis) $100,000–$180,000. Ultrasound (Ultherapy, Sofwave) $80,000–$140,000. Cryolipolysis (CoolSculpting) $50,000–$80,000 per unit. Prices vary by geography, distributor, and whether you're buying direct or through a group purchasing organization (GPO). Manufacturer loyalty programs—Allergan's Alle, Galderma's Aspire, Evolus Rewards—sometimes bundle device discounts with toxin/filler rebates, but read the fine print: volume commitments and clawback clauses can lock you in. Always request a demo and trial period before purchase; many manufacturers offer 30–60 day trials.

Purchase outright requires capital, depreciates over 5–7 years (MACRS), and locks you into one platform. Lease (typically 36–60 months) spreads cost as an operating expense, preserves cash, and lets you upgrade when the lease ends—critical in a fast-moving market. Lease-to-own hybrids let you apply lease payments toward eventual purchase. Monthly lease payments typically run 2–3% of equipment cost; a $100,000 device leases for roughly $2,000–$3,000/month over 60 months. Consult your accountant on whether lease payments are fully deductible in your state and practice structure (S-corp, LLC, C-corp treatment differs). Some practices finance via equipment lenders at 6–10% APR, which can be cheaper than manufacturer leases if you negotiate hard. Compare total cost of ownership: lease + service + supplies vs. purchase + depreciation + maintenance contracts (often $3,000–$8,000/year).

Breakeven depends on three variables: monthly lease/depreciation cost, per-procedure revenue, and per-procedure variable cost (supplies, staff time). Example: $100,000 RF device leased at $2,500/month. If you charge $400 per RF microneedling session and supplies cost $40, your contribution margin is $360/procedure. Breakeven = $2,500 ÷ $360 = ~7 procedures/month, or 1.6/week. That's conservative; most practices need 12–20/month to justify the device and cover overhead. If you're doing 4–5 RF treatments daily (realistic for a busy practice), you hit breakeven in the first 1–2 weeks of the month and profit the rest. Underutilization is the killer. A device running 2–3 times weekly in a slow practice may never reach breakeven. Model your realistic patient volume honestly: survey your existing client base, check local competitor pricing and frequency, and talk to sales reps about typical utilization rates in your market.

Alle (AbbVie/Allergan Aesthetics), Aspire (Galderma), and Evolus Rewards tie device discounts to toxin/filler volume commitments. Example: buy $50,000+ in Botox annually, get $10,000 off a Morpheus8 lease. These programs are real savings—but read the contract. Clawback clauses can require you to repay discounts if you fall short of volume targets mid-year. Some programs lock you into single-source purchasing (you must buy all your Botox from Allergan, not a competitor), which limits your negotiating power on per-unit pricing. Evaluate whether the device discount justifies the exclusivity cost. Also ask: does the rebate apply to the lease payment, or is it a separate credit? Can you stack rebates across multiple programs? Manufacturers' terms change quarterly; always get current terms in writing.

Service contracts (preventive maintenance, repairs) typically cost 8–12% of equipment purchase price annually—$8,000–$18,000 for a $100,000–$150,000 device. Some leases include service; others don't. Supplies vary by modality: RF microneedling tips/cartridges ($50–$200 per treatment), laser consumables, cooling gel, handpiece replacements. Budget $30–$100 per procedure in supplies. Training and certification for staff: $1,000–$5,000 per technician, often required by manufacturer. Downtime risk: a broken laser during peak season can cost $5,000–$10,000 in lost revenue. Consider whether the manufacturer offers loaner equipment or rapid turnaround. Ask about parts availability and whether repairs are done on-site or require shipping (turnaround can be 2–4 weeks). Factor these into your ROI model; they're often overlooked.

Used devices can cut acquisition cost by 40–60% but carry risks. Verify service history, remaining warranty, and whether the manufacturer will service it (some won't). A $150,000 new RF system selling used for $60,000 is tempting—but if it fails and repair costs $15,000 with a 6-week lead time, you've lost margin and patient trust. Refurbished units (manufacturer-reconditioned) are safer; they come with a warranty and have been tested. Expect to pay 60–75% of new price. Buy refurbished only from authorized distributors, not third-party resellers. Always negotiate a trial period (14–30 days) and get a written statement of condition. Check whether the device is still receiving software updates and whether consumables will remain available (older platforms sometimes get discontinued).

InMode (Morpheus8, Lumenis platforms) received an unsolicited acquisition proposal in mid-2026, signaling potential ownership change. Allergan Aesthetics (AbbVie) continues expanding its device portfolio alongside injectables. Consolidation affects you: new ownership can change warranty terms, service availability, pricing, and software support. Before buying or leasing, research the manufacturer's financial stability and market position. If a company is acquired or goes private, will your device still be supported in 3–5 years? Ask the sales rep directly: what's your company's long-term commitment to this platform? Get service and parts availability guarantees in writing. Diversify your device portfolio—don't rely on a single manufacturer for your entire revenue stream.

Practice A (urban, 8 providers, high volume): Leases Morpheus8 at $2,200/month, does 18 RF treatments/week at $450 each (supplies $50). Weekly contribution margin: 18 × ($450 − $50) = $7,200. Monthly: ~$28,800. Lease cost: $2,200. Monthly profit: $26,600. ROI: 12× in year one. Practice B (suburban, 2 providers, moderate volume): Purchases same device for $120,000 (5-year depreciation = $24,000/year or $2,000/month), does 6 RF treatments/week. Weekly margin: 6 × $400 = $2,400. Monthly: ~$9,600. Depreciation + service ($500/month) = $2,500. Monthly profit: $7,100. ROI: 3.5× in year one, breakeven in month 3. Practice C (rural, 1 provider, low volume): Leases device at $2,200/month, does 2 RF treatments/week. Monthly margin: 2 × $400 × 4.3 weeks = $3,440. Lease cost: $2,200. Monthly loss: −$1,240. This practice should not buy or lease this device until volume increases.